The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
June 7th 2023
It’s time for pharmacies to take a page out of the books of hospitals and tech companies by expanding and streamlining their use of contingent labor.
AI, Machine Learning Improve Patient Care, Can Empower Health Care ProfessionalsMay 5th 2023
There are still significant unresolved issues in artificial intelligence and machine learning, which must be addressed before they can be safely and effectively used more broadly in medicine.
Illegal Online Pharmacies Are Growing, Pose a Significant Problem to US Public HealthMay 5th 2023
Illegal online sellers threaten the health, privacy, and security of patients by failing to comply with the laws of the jurisdiction in which they are located, or the jurisdiction in which they are selling their medicines.
Improved Training Needed for Sexual Health Promotion, HIV Prevention in Individuals With Mental Health ProblemsMay 5th 2023
Mental health interventions are a critical part of the global response to HIV, with multiple potential roles for psychiatrists and other mental health professionals.
The Role of the Pharmacy Technician Expands into Pharmacy-Based Community Health WorkerMay 3rd 2023
The advent of pharmacy-based community health workers has helped to expand and codify the pre-existing community-based efforts of pharmacy technicians to reach even outside of medication access.
FDA Approves First Respiratory Syncytial Virus Vaccine for Adults Aged 60 Years and OlderMay 3rd 2023
Arexvy is the first respiratory syncytial virus (RSV) vaccine approved in the United States for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
The Impact of a Clinical Pharmacist on Immunosuppressive Medication Adherence in Kidney Transplant Patients
Studies show that patients who had pharmacists as part of their transplant-related care had a significant improvement in clinical outcomes.
Monoclonal Antibody Therapy Effective at Reducing Risk of Death From COVID-19 in Unvaccinated, Vaccinated PatientsMay 3rd 2023
Neutralizing monoclonal antibody therapies found to improve outcomes for unvaccinated and nonhospital patients at high risk of poor outcome for SARS-CoV-2.
New Phase 3 Trial Data Show Eplontersen Improved Neuropathy in Over Half of Patients With Hereditary Transthyretin-Mediated Amyloid PolyneuropathyMay 3rd 2023
Study shows eplontersen maintains a consistent and sustained treatment effect and reinforces its potential treating hereditary transthyretin-mediated amyloid polyneuropathy, which can lead to heart failure.